In recent years, we’ve seen an increasing number of Life Sciences companies publicly declare commitments to sustainability efforts as a result of increased pressure from governments, customers, and research. Trending Health UK’s Ollie May sits down with two members of Vynamic’s Sustainability Council, Rosanna Vellacott and Matt O’Dell, to discuss why pharmaceutical organizations should be paying attention to sustainability goals, some innovative practices underway, and what leaders should be considering as they embed more sustainable practices into their organizations.
Podcast Tags: healthcare, life sciences, sustainability, healthcare news, climate change, climate crisis, emissions, net zero, supply chain
Source Links:
- Striving for sustainable drug discovery using Green Chemistry
- Accelerating the transition to net zero in life sciences
- Sanofi harnesses Dassault\’s digital twin tech to optimize production at future vaccine plants
- Strategies for Sustainability in the Global Pharmaceutical Supply Chain
- Bayer: Improving Sustainability Practices in the Supply Chain
- Bayer: Commitments in Action Creating a Sustainable Product Supply
- Making biopharma’s supply chains more environmentally sustainable
- The pharma companies working towards supply chain sustainability
- Carbon footprint of the global pharmaceutical industry and relative impact of its major players
- The Greenhouse Gas Protocol: Technical Report
- Understanding pharma’s challenges and opportunities in relation to the climate crisis
- Pharmaceutical Company Targets and Strategies to Address Climate Change: Content Analysis of Public Reports from 20 Pharmaceutical Companies
- Pharma’s path to Net Zero: Targeting Scope 3 emissions
Panel – Oliver May, Rosanna Vellacott, Matt O’Dell
Research & Production – Adrea Cope, Everly Petruzzelli, Oliver May
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
POWERED BY BLUBRRY
